Radiopharm Theranostics Limited American Depositary Shares (RADX) Stock Price

RADXStock

$2.41−67.86%52W

Market Cap$34.84M

P/E—

PEG Ratio—

Div yield—

Beta0.20

RADX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-71.02%

Price vs S&P 500 (4W)-32.31%

VGM Score43.83

Book Value / Share (Quarterly)$0.01

P/TBV (Annual)2.59x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.01

Price vs S&P 500 (YTD)-75.87%

Net Profit Margin (TTM)-1236.29%

EPS (TTM)$-0.01

10-Day Avg Trading Volume11.42M

EPS Excl Extra (TTM)$-0.01

EPS (Annual)$-0.01

ROI (Annual)-81.94%

Gross Margin (Annual)1.08%

Cash / Share (Quarterly)$0.01

Revenue Growth QoQ (YoY)0.14%

ROA (Last FY)-42.44%

Revenue Growth TTM (YoY)116.02%

EBITD / Share (TTM)$-0.01

Operating Margin (TTM)-1283.95%

Cash Flow / Share (Annual)$-0.01

P/B Ratio1.01x

P/B Ratio (Quarterly)1.71x

Net Income / Employee (Annual)$-1,878,051

EV / Revenue (TTM)4.82x

Net Interest Coverage (TTM)-7.52x

ROA (TTM)-50.60%

EPS Incl Extra (Annual)$-0.01

Current Ratio (Annual)2.67x

Quick Ratio (Quarterly)3.01x

3-Month Avg Trading Volume5.32M

52-Week Price Return-67.86%

Revenue / Employee (TTM)$186,043

Tangible BV / Share (Quarterly)$0.00

P/S Ratio (Annual)14.33x

Asset Turnover (Annual)0.04x

52-Week High$0.03

EPS Excl Extra (Annual)$-0.01

26-Week Price Return-59.09%

Quick Ratio (Annual)2.67x

13-Week Price Return-55.00%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.01x

Enterprise Value$12.56M

Asset Turnover (TTM)0.04x

Revenue / Employee (Annual)$185,900

Pretax Margin (Annual)-1052.43%

Cash / Share (Annual)$0.01

3-Month Return Std Dev95.17%

Net Income / Employee (TTM)$-2,299,710

ROE (Last FY)-81.94%

Net Interest Coverage (Annual)-6.86x

EPS Basic Excl Extra (Annual)$-0.01

Receivables Turnover (TTM)0.41x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.01

Receivables Turnover (Annual)0.64x

ROI (TTM)-93.08%

P/S Ratio (TTM)14.32x

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.02

Price vs S&P 500 (52W)-86.42%

Year-to-Date Return-64.00%

5-Day Price Return-18.18%

EPS Normalized (Annual)$-0.01

ROA (5Y Avg)-328.52%

Net Profit Margin (Annual)-1010.15%

Month-to-Date Return-35.71%

EBITD / Share (Annual)$-0.01

Operating Margin (Annual)-1050.63%

EPS Basic Excl Extra (TTM)$-0.01

P/TBV (Quarterly)13.22x

P/B Ratio (Annual)1.16x

Pretax Margin (TTM)-1287.55%

Book Value / Share (Annual)$0.01

Price vs S&P 500 (13W)-56.95%

Beta0.20x

Revenue / Share (TTM)$0.00

ROE (TTM)-93.08%

52-Week Low$0.01

vGradeC

gGradeB

mGradeF

vgmGradeC

RADX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
RADXRadiopharm Theranostics Limited American Depositary Shares	C	B	F	$2.41
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Radiopharm Theranostics Limited American Depositary Shares

Radiopharm Theranostics is an Australian clinical-stage radiotherapeutics company targeting cancer with approximately four licensed platform technologies. The company develops diagnostic and therapeutic solutions across pre-clinical and clinical development stages.